Biogen Inc.
BIIB
$210.73
-$1.77-0.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -45.47% | -7.26% | -20.79% | -0.41% | 32.10% |
| Total Depreciation and Amortization | 13.25% | 13.01% | 15.85% | 21.36% | 30.24% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 113.66% | 94.34% | 63.99% | 40.30% | -12.66% |
| Change in Net Operating Assets | 65.10% | -227.69% | -581.44% | -10.70% | -14.65% |
| Cash from Operations | 36.00% | 0.36% | -23.33% | 15.35% | 18.66% |
| Capital Expenditure | -32.03% | -15.87% | -0.07% | 16.93% | 36.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -371.26% | -- | -- | 100.00% | 84.48% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 25.22% | -410.88% | -383.55% | -102.14% | -101.77% |
| Cash from Investing | -307.63% | -96.45% | -71.56% | 88.97% | 34.60% |
| Total Debt Issued | 38.44% | -- | -- | -- | 73.83% |
| Total Debt Repaid | 21.33% | -712.00% | -212.31% | -34.62% | -19.87% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -126.19% | -52.66% | 85.07% | -273.60% | 14.29% |
| Cash from Financing | 3,049.10% | -20.91% | 55.83% | 88.26% | 93.07% |
| Foreign Exchange rate Adjustments | -131.30% | 581.55% | 250.52% | -54.21% | 527.88% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -273.41% | -48.53% | -52.19% | 467.52% | 219.89% |